Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Psyence Biomedical Ltd (PBM)

Psyence Biomedical Ltd (PBM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Psyence Biomedical Ltd. Announces Share Consolidation Effective November 26, 2024 Quiver Quantitative, Inc. - Wed Nov 20, 1:20AM CST

Psyence Biomedical Ltd. announced a 1-for-75 share consolidation effective November 26 to comply with Nasdaq listing requirements.Quiver AI SummaryPsyence Biomedical Ltd. announced the effective date of...

PBM : 0.0525 (-2.60%)
Psyence Biomedical Announces Effective Date for 1-for-75 Share Consolidation GlobeNewswire - Tue Nov 19, 3:05PM CST

PBM : 0.0525 (-2.60%)
Psyence Biomedical Announces Results from Annual and Special General Meeting, Share Consolidation and Receipt of Additional Staff Determination from Nasdaq GlobeNewswire - Tue Nov 12, 3:30PM CST

PBM : 0.0525 (-2.60%)
Psyence Biomedical Announces Closing of Previously Announced Acquisition of Psyence Group’s Stake in PsyLabs GlobeNewswire - Thu Oct 31, 6:30AM CDT

PBM : 0.0525 (-2.60%)
Psyence Biomed Announces Recruitment of Second Clinical Trial Site for Ongoing Phase IIb Clinical Trial of Nature-Derived Psilocybin for Adjustment Disorder in Palliative Care GlobeNewswire - Thu Oct 24, 6:00AM CDT

PBM : 0.0525 (-2.60%)
Psyence Biomed Provides Progress Update on PsyLabs E.U. Good Manufacturing Practices (GMP) Certified Active Pharmaceutical Ingredient (API) Development GlobeNewswire - Thu Oct 17, 6:00AM CDT

PBM : 0.0525 (-2.60%)
Psyence Biomed Provides Update on Previously Announced Acquisition of Clairvoyant GlobeNewswire - Fri Oct 4, 3:05PM CDT

PBM : 0.0525 (-2.60%)
Optimi Health and Psyence Biomedical Sign Non-Binding Letter of Intent to Advance Global Psilocybin Drug Development Newsfile - Tue Aug 13, 6:38AM CDT

Vancouver, British Columbia and New York, New York--(Newsfile Corp. - August 13, 2024) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi"), a GMP-approved, Health Canada licensed psychedelics...

PBM : 0.0525 (-2.60%)
OPTHF : 0.1422 (+1.57%)
OPTI.CN : 0.2050 (+2.50%)

Barchart Exclusives

Nasdaq Futures Tread Water as Investors Brace for Nvidia Earnings Barchart - 1 hour ago
December Nasdaq 100 E-Mini futures (NQZ24) are trending up +0.09% this morning as investors shifted their focus to a highly anticipated earnings report from AI darling Nvidia. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot